336 related articles for article (PubMed ID: 4701111)
21. Diagnostic and predictive performance and standardized threshold of traditional biomarkers for drug-induced liver injury in rats.
Tonomura Y; Kato Y; Hanafusa H; Morikawa Y; Matsuyama K; Uehara T; Ueno M; Torii M
J Appl Toxicol; 2015 Feb; 35(2):165-72. PubMed ID: 25186495
[TBL] [Abstract][Full Text] [Related]
22. Hepatotoxicity due to treatment with papaverine. Report of four cases.
Ronnov-Jessen V; Tjernlund A
N Engl J Med; 1969 Dec; 281(24):1333-5. PubMed ID: 5355438
[No Abstract] [Full Text] [Related]
23. Five-year follow-up study of patients with nonalcoholic and nondiabetic fatty liver.
Massarrat S; Jordan G; Sahrhage G; Korb G; Bode JC; Dölle W
Acta Hepatogastroenterol (Stuttg); 1974 Jun; 21(3):176-86. PubMed ID: 4450977
[No Abstract] [Full Text] [Related]
24. Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy.
Helman RA; Temko MH; Nye SW; Fallon HJ
Ann Intern Med; 1971 Mar; 74(3):311-21. PubMed ID: 4928161
[No Abstract] [Full Text] [Related]
25. [Demonstration by lymphocyte transformation test of the allergic genesis in a case of acute hepatitis].
Federmann G; Becker EW; Tautorat H; Penschuck C; Berg PA
Dtsch Med Wochenschr; 1988 Oct; 113(43):1676-9. PubMed ID: 2903041
[TBL] [Abstract][Full Text] [Related]
26. [Elevated liver enzymes].
Panther E; Blum HE
MMW Fortschr Med; 2010 Sep; 152(37):34-5. PubMed ID: 21192451
[No Abstract] [Full Text] [Related]
27. [Liver function tests in solvent-exposed workers in the metal processing industry].
Szadkowski D; Körber M
Int Arch Arbeitsmed; 1969 Dec; 25(4):323-37. PubMed ID: 5370816
[No Abstract] [Full Text] [Related]
28. Early identification of carbon tetrachloride hepatotoxicity in albino rats.
Said MM; Ibrahim MH; Mekkawy MY
Pharmazie; 1984 Jan; 39(1):64-5. PubMed ID: 6718473
[No Abstract] [Full Text] [Related]
29. [Drug-induced liver disorders. Questions for Professor Daniel Dhumeaux].
Gastroenterol Clin Biol; 1999; 23(8-9):917-20. PubMed ID: 10533145
[No Abstract] [Full Text] [Related]
30. Liver disease in the drug-using adolescent.
Litt IF; Cohen MI; Schonberg SK; Spigland I
J Pediatr; 1972 Aug; 81(2):238-42. PubMed ID: 5042483
[No Abstract] [Full Text] [Related]
31. [Clinical and biopsy studies on the course of fatty liver hepatitis].
Denk H; Leodolter I; Schnack H; Thaler H
Wien Klin Wochenschr; 1970 Feb; 82(6):98-101. PubMed ID: 5513205
[No Abstract] [Full Text] [Related]
32. Significance of the LP-X test in differential diagnosis of jaundice.
Seidel D; Gretz H; Ruppert C
Clin Chem; 1973 Jan; 19(1):86-91. PubMed ID: 4345750
[No Abstract] [Full Text] [Related]
33. [Evaluation of routine serochemical methods for the study of liver involvement in diabetes mellitus].
Heller H
Z Gesamte Inn Med; 1971 May; 26(10):Suppl:120-4. PubMed ID: 5131405
[No Abstract] [Full Text] [Related]
34. Elevated SGOT/SGPT ratio in alcoholic patients with acetaminophen hepatotoxicity.
Himmelstein DU; Woolhandler SJ; Adler RD
Am J Gastroenterol; 1984 Sep; 79(9):718-20. PubMed ID: 6475903
[TBL] [Abstract][Full Text] [Related]
35. The significance of Mallory bodies in the progression of fatty liver into cirrhosis.
Christoffersen P; Juhl E
Acta Pathol Microbiol Scand A; 1974 Jul; 82(4):483-6. PubMed ID: 4137298
[No Abstract] [Full Text] [Related]
36. [Changes in liver enzymes during treatment with diltiazem. Description of 2 cases].
Romanò M; Colombo E; Spinelli A
G Ital Cardiol; 1987 Feb; 17(2):149-50. PubMed ID: 2886392
[TBL] [Abstract][Full Text] [Related]
37. [Liver damage after administration of pyrazinamide in animal experiments. 3. Biochemical changes in liver tissue and blood serum].
Celikovská G; Stastná J; Zítková L; Brezinová H; Kürti V
Arzneimittelforschung; 1970 Jan; 20(1):155-7. PubMed ID: 5467442
[No Abstract] [Full Text] [Related]
38. [Diagnostic significance of serum -glucuronidase. 3. Behavior of serum -glucuronidase activity in liver diseases in comparison to other clinical and chemical study results].
Nilius R
Z Gesamte Inn Med; 1971 Jun; 26(12):384-93. PubMed ID: 5122587
[No Abstract] [Full Text] [Related]
39. [Enzyme diagnosis and liver diseases].
Schmidt E; Schmidt FW
Schweiz Med Wochenschr; 1969 Apr; 99(15):514-21. PubMed ID: 5784493
[No Abstract] [Full Text] [Related]
40. [Multivariant analysis of experimental liver damage: normal parameters of the rat serum].
Rauen HM; Schriewer H; Gebauer B; Abu Tair M; Rüther N; The LG
Arzneimittelforschung; 1973 Jan; 23():Suppl:108-16. PubMed ID: 4740676
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
